Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.40 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | GRM8 | O00222 | 1/20 | 0.36 |
| ▸ | GRM6 | O15303 | 1/20 | 0.36 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.36 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL4647428 | 1.00 | — | — | |
| SCHEMBL209221 | 0.96 | — | — | |
| SCHEMBL29278533 | 0.92 | — | — | |
| SCHEMBL4648068 | 0.92 | — | — | |
| Bicarbonate SCHEMBL10985561 | 0.92 | SLC7A5 (0.42) | SLC7A5PTGS1SLC7A11ALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL6319147 | 0.92 | — | — | |
| Ethylene Glycol SCHEMBL14742401 | 0.82 | PTGS1 (0.41) | SLC7A5PTGS1SLC7A11GRM2CYP1A2 | |
| Malonic Acid SCHEMBL9786773 | 0.79 | LDHA (0.56) | SLC7A5PTGS1SLC7A11TDP1GRM2 | |
| Glycine SCHEMBL29262363 | 0.79 | GLRA1 (0.62) | SLC7A5PTGS1SLC7A11TSHRLMNA | |
| Ethylenediamine SCHEMBL10898680 | 0.79 | GSR (0.44) | SLC7A5PTGS1SLC7A11TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0930844-B8 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT | LANTHEUS MEDICAL IMAGING INC (US) | 2008-11-26 | — | — | EP | disclosed |
| US-7452551-B1 | Targeted compositions for diagnostic and therapeutic use | IMARX THERAPEUTICS, INC. (US) | 2008-11-18 | — | — | US | disclosed |
| EP-0930844-B1 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT | IMARX PHARMACEUTICAL CORP (US) | 2008-09-03 | — | — | EP | disclosed |
| EP-1015039-B1 | OXYGEN DELIVERY AGENTS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP (US) | 2008-08-27 | — | — | EP | disclosed |
| US-7329402-B2 | Methods of imaging and treatment | IMARX PHARMACEUTICAL CORP. (US) | 2008-02-12 | — | — | US | disclosed |
| EP-1017425-B1 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY VASODILATOR | IMARX PHARMACEUTICAL CORP (US) | 2007-10-17 | — | — | EP | disclosed |
| EP-1323434-B1 | Method for diagnostic imaging of the renal region using a contrast agent and a vasodilator | IMARX PHARMACEUTICAL CORP (US) | 2007-07-11 | — | — | EP | disclosed |
| US-20070059248-A1 | Oxygen delivery agents and uses for the same | IMARX THERAPEUTICS, INC. | 2007-03-15 | — | — | US | disclosed |
| US-7105151-B2 | Oxygen delivery agents and uses for the same | IMARX THERAPEUTICS, INC. (US) | 2006-09-12 | — | — | US | disclosed |
| EP-1037673-B1 | CHARGED LIPIDS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP (US) | 2006-08-23 | — | — | EP | disclosed |
| EP-0831927-A1 | STABILIZED COMPOSITIONS OF FLUORINATED AMPHIPHILES AS CONTRAST AGENTS FOR ULTRASOUND | IMARX PHARMACEUTICAL CORP. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1998010798-A1 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR | IMARX PHARMACEUTICAL CORP. (US) | 1998-03-19 | — | — | WO | disclosed |
| WO-1998010799-A1 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY VASODILATOR | IMARX PHARMACEUTICAL CORP. (US) | 1998-03-19 | — | — | WO | disclosed |
| WO-1998009600-A2 | NOVEL SILICON AMPHIPHILIC COMPOUNDS AND THE USE THEREOF | IMARX PHARMACEUTICAL CORP. (US) | 1998-03-12 | — | — | WO | disclosed |
| EP-0818989-A1 | NOVEL COMPOSITIONS OF LIPIDS AND STABILIZING MATERIALS | IMARX PHARMACEUTICAL CORP. (US) | 1998-01-21 | — | — | EP | disclosed |
| US-5705187-A | Compositions of lipids and stabilizing materials | IMARX PHARMACEUTICAL CORP. (US) | 1998-01-06 | — | — | US | disclosed |
| WO-1997048337-A1 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT | IMARX PHARMACEUTICAL CORP. (US) | 1997-12-24 | — | — | WO | disclosed |
| WO-1996040285-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996039197-A1 | STABILIZED COMPOSITIONS OF FLUORINATED AMPHIPHILES AS CONTRAST AGENTS FOR ULTRASOUND | IMARX PHARMACEUTICAL CORP. (US) | 1996-12-12 | — | — | WO | disclosed |
| WO-1996031196-A1 | NOVEL COMPOSITIONS OF LIPIDS AND STABILIZING MATERIALS | IMARX PHARMACEUTICAL CORP. (US) | 1996-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070059248-A1 | Oxygen delivery agents and uses for the same | VEGFA, PGF, SLCO2A1 | SLC7A5 1777/4885PTGS1 877/4885SLC7A11 2249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.